Swiss Medica XXI Century

Swiss Medica XXI Century is a private medical network specializing in regenerative medicine and advanced stem cell therapies. The company provides treatment programs for a variety of chronic and degenerative conditions, including multiple sclerosis, Parkinson's disease, type 2 diabetes, and ALS. Their clinical approach utilizes mesenchymal stem cells (MSCs) derived from autologous sources like adipose tissue and bone marrow, as well as allogeneic sources such as umbilical cord and placenta. With primary clinical operations in Belgrade, Serbia, and Moscow, Russia, Swiss Medica integrates cell-based treatments with comprehensive rehabilitation and supportive therapies. The organization focuses on the clinical application of cellular products rather than traditional pharmaceutical drug development, positioning itself as a leader in the medical tourism sector for regenerative medicine.